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Background: We report two cases of unilateral upper eyelid swelling with multiple small lumps as an unusual
complication of autogenous fat injection for cosmetic forehead augmentation.
Case presentation: Two female patients were referred to our clinic for unusual unilateral eyelid swelling, with
multiple small lumps. The duration of symptoms differed in each case, but both patients had a history of
autogenous fat injection for cosmetic forehead augmentation at a local plastic surgery clinic. The lumps were small
(diameter 5 mm~10 mm), palpable, hard, and nonmobile, and were evaluated by magnetic resonance imaging
(MRI). Lumps from the eyelids of two patients were excised under general anesthesia. All of the masses were
located deeply and found near the superior orbital rim or lateral orbital rim. The lumps exhibited chronic
inflammation with fibrosis. Some of the lumps showed foamy histiocytic aggregation and foreign body
lipogranuloma, resulting from iatrogenic fat injection. After excision, all masses and swelling disappeared, and
moderate ptotic eyelid or lagophthalmos of affected eyes also improved.
Conclusions: To our knowledge, eyelid swelling with multiple lumps in the eyelid is a very rare complication of
autogenous fat injection for cosmetic forehead augmentation. This report should be helpful for ophthalmic
clinicians who encounter these unusual symptoms.
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Autogenous fat is an easily accessible, renewable re-
source that can be harvested from multiple sites with lit-
tle or no morbidity. After transfer to other locations,
autogenous fat serves as non-allergenic, well-tolerated,
supple, and versatile implant material. Therefore, au-
togenous fat injection into the periorbital or mid-face re-
gion is a common type of cosmetic surgery for
rejuvenation in middle-aged and older Western subjects.
In Asians, autogenous fat injection has become increas-
ingly popular for forehead augmentation in relatively
young people to enhance the esthetics of the typical flat
Asian forehead. Although autogenous fat has good long-
term safety and no severe adverse reactions, we encoun-
tered a case series of eyelid swelling with multiple mass-
like lesions after dermal injection of autogenous fat.
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A 26-year-old woman complained of eyelid swelling and
blepharoptosis of the right upper lid for 1 month that had
developed slowly over the previous 6 months. On examin-
ation, a small mass 2~3 mm in diameter was seen laterally
and another small mass measuring 5~7 mm in diameter
was seen medially; these masses were not easily movable
and poorly demarcated. A medially placed mass was pal-
pated deeply near the superior orbital rim. No tenderness
or skin discoloration was noted. Moderate blepharoptosis
of the right upper lid was observed (Figure 1A). Magnetic
resonance imaging (MRI) with enhancement revealed a
diffuse enhancing mass that was larger than the clinically
palpated mass (Figure 1C). On further questioning, the pa-
tient reported that she had twice received autogenous fat
injection for forehead augmentation at a clinic. The first
injection used fresh autogenous fat from her thighs and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Case 1. A) Preoperatively, this patient had mild eyelid swelling with moderate blepharoptosis and multiple small nodules palpable
deeply around the medial superior orbital rim. B) One month postoperatively, the masses and eyelid swelling had disappeared, and the
blepharoptosis had been corrected. C) Preoperative MRI scanning. D) A photograph during surgery. The largest excised mass consisted of
granulation tissue measuring 10× 6 mm. E) Microscopically, the specimen contained chronic inflammatory cells with fibrohistiocytic proliferation
surrounded by amorphous collagenous material (H&E stain, ×100, ×400 with magnification). Histiocytes were positive for CD68 (×100, ×400
with magnification).
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had been stored frozen for one month after the first injec-
tion. She had undergone upper eyelid blepharoplasty via
an incision 7 years earlier. Therefore, we planned a surgi-
cal excision using an eyelid crease skin incision in the
upper eyelid. During the surgical procedure, the tissue be-
tween the orbital septum and preaponeurotic fat was gen-
tly dissected. Thick adhesions and fibrosis were removed,
and gray-pink colored masses were found near theFigure 2 Case 2. A) Preoperatively, this patient had small nodoular masse
remained and mild lagophthalmos was improved. C) Coronal and axial enh
excised masses (9×7 mm) of Case 2. Microscopically, the specimen contain
(H&E stain, ×100, ×400 with magnification).superior orbital rim. During excision, grayish jelly-like ma-
terial was found around and within the masses. The
masses did not have distinct boundaries and were not eas-
ily separated and removed (Figure 1D), because they ad-
hered firmly to the surrounding structures. Microscopic
examination of the specimen showed marked chronic in-
flammation with pseudogranulomatous foamy histiocytic
aggregation, which was confirmed to be a lipid-phagocytic
reaction or oil-associated foreign body reaction and fats with mild lagophtlmos. B) Two months postoperatively, no mass
anced MRI views showing diffuse eyelid enhancing. D) The largest
ed chronic inflammation with foreign body lipogranuloma
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immediately after surgery, but 1 month later, the
blepharoptosis and swelling had disappeared almost com-
pletely (Figure 1B). No masses were seen 18 months after
surgery.
Case 2
A 30-year-old female visited our clinic for frequent
upper eyelid swelling and a palpable medially located
mass with lid lag and 2 mm lagophthalmos (Figure 2A).
Although there were no definite findings, the patient
wanted further evaluation and treatment. She said that
the mass had recently enlarged and that laterally, a new
small mass had developed. The patient had received
rhinoplasty and autogenous fat injection in the forhead
in March 2011 at a local plastic surgery clinic. Nine
months after surgery, the above-mentioned symptoms
developed. At first visit, MRI scans showed a highly en-
hanced mass in her left upper eyelid (Figure 2C). The
surgically removed mass was 8~9 mm in diameter with
chronic inflammation and foreign body lipogranuloma
(Figure 2D). Six months after surgery, the mass and
swelling had disappeared, and lid lag and lagophthalmos
were also improved (Figure 2B).
The clinical characteristics of two patients were sum-
marized (Table 1).
Discussion
Autogenous fat is an excellent material for filling spot de-
fects, such as depressed scars, and area defects, such as
trough and sulcus deformities. Autogenous fat is easily ac-
cessible for harvesting and is available in adequate quan-
tities for injection, even in lean patients. The fat is readily
accepted at the implantation site due to its autogenous na-
ture [1]. Facial injections, including periocular and
paranasal injections of various substances, are becoming
common as more procedures are performed under local
anesthesia [2-4]. In young Asian subjects, autogenous fat
injection for forehead augmentation is becoming increas-
ingly popular to improve facial esthetics.
Complications of autogenous fat injection include a
visible lump, the collection of fat at the injection site, an
uneven skin surface, and allergic reactions to albumin or
anesthetic agents. A rare, but potentially devastating,Table 1 The clinical characteristics of two patients
Case Symptoms Surgery at plastic surgery / Symptom
onset after 1st injection/ visit our clinic
1 Lumps, Ptosis Forehead augmentation / 7 months/
13 months after 1st inection
2 Lumps, Swelling Forehead augmentation with rhinoplsty /
9 monnths / 12months after 1st injection
Yes* means the patient received additional fat injection using frozen storage autogcomplication is embolization with loss of vision or stroke,
which has been recently reported. The visual loss can re-
sult from retinal ischemia caused by occlusion of the oph-
thalmic and central arteries by fat emboli [5,6]. To our
knowledge, however, there have been no previous reports
of eyelid swelling with multiple lumps with or without
blepharoptosis that regressed after surgical removal. The
pathogenesis of eyelid swelling with small masses after au-
togenous fat injection for forehead augmentation could be
explained by incorrect injection and/or anatomical varia-
tions of the forehead. One patient in this report received
two injections of autogenous fat. The relatively short
period between injections (in this patient, 4 weeks) suggest
that overcorrection may have played a role in the develop-
ment of complications. Furthermore, repeat injections
generally used previously harvested fat stored in a freezer;
and it is possible that this fat was less vital, less oxygen-
ated, and did not survive well. The other patients who re-
ceived a single injection received a relatively large volume
of fat (0.3~0.5 ml), which may have been injected into the
same area. This could become necrotic in less oxygenated
areas and descend along the musculoaponeurotic system
of the forehead to reach the superior orbital rim or lateral
orbital rim, developing adhesions, fibrosis, and chronic in-
flammation, to ultimately form a cicatrix.
Conclusions
Frequent eyelid swelling and multiple lumps with or with-
out blepharoptosis are rare but potentially serious com-
plications resulting from autogenous fat injection of
the forehead. Here, we present the first report describing
such adverse reactions and their treatment. Although
blepharoptosis was not severe, if it progresses and does
not improve with systemic anti-inflammatory medications,
surgical intervention might be necessary, as it was in Case
1. Two patients were no longer suffered from frequent
eyelid swelling after the masses were completely removed.
Finally, if non-absorbable fatty tissue remains at the fore-
head, at the first injection site, it could move inferiorly and
cause upper eyelid complications.
Consent
Written informed consent was obtained from both pa-
tients for publication of this case report and anyAdditional
fat inection
Histopathogical findings Postoperatively





No Chronic inflammation with
foreign body lipogranuloma
No recur Still remained
lagophthalmos, lid lag
enous fat tissue.
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